The effect of metformin on breast cancer outcomes in patients with type 2 diabetes

Keyphrases

• Metformin 100%
• Type 2 Diabetic Patients 100%
• Breast Cancer Outcomes 100%
• Metformin Use 66%
• Breast Cancer Diagnosis 50%
• Recurrence-free Survival 50%
• Breast Cancer 33%
• Chemotherapy 33%
• Patients with Diabetes 33%
• Overall Survival 33%
• Contralateral Breast Cancer 33%
• Improved Outcomes 16%
• Diabetes 16%
• Type 2 Diabetes Mellitus (T2DM) 16%
• Clinical Presentation 16%
• Invasive Breast Cancer 16%
• Breast Cancer Mortality 16%
• Systemic Chemotherapy 16%
• Observational Data 16%
• Diabetes Diagnosis 16%
• Non-associated 16%
• Recurrence Rate 16%
• Inclusion Criteria 16%
• Tumor Characteristics 16%
• Women with Diabetes 16%
• Kaplan-Meier Method 16%
• Steroid-induced Diabetes 16%
• Institutional Database 16%

Medicine and Dentistry

• Breast Cancer 100%
• Patient with Type 2 Diabetes 100%
• Glycon 100%
• Diabetes 33%
• Chemotherapy 25%
• Cancer Diagnosis 25%
• Recurrence Free Survival 25%
• Patient with Diabetes 16%
• Contralateral 16%
• Overall Survival 16%
• Neoplasm 8%
• Maturity Onset Diabetes of the Young 8%
• Cancer Incidence 8%
• Kaplan Meier Method 8%

Nursing and Health Professions

• Patient with Type 2 Diabetes 100%
• Metformin 100%
• Breast Cancer 100%
• Cancer Diagnosis 25%
• Recurrence Free Survival 25%
• Patient with Diabetes 16%
• Overall Survival 16%
• Non Insulin Dependent Diabetes Mellitus 8%
• Cancer Incidence 8%
• Kaplan Meier Method 8%
• Neoplasm 8%